Our Solutions

Solutions

Powered by the QAI Platform

QAI is our proprietary quantum-inspired AI intelligence platform. It serves as the core engine that lets us rapidly develop, train, and deploy an entire suite of non-invasive health and safety products. Every solution — from impairment screening to remote monitoring is built on proprietary AI models, real-world dataset of 720,000+ scans, and quantum optimization layer. This platform approach means faster innovation, consistent accuracy, and easy customization for new verticals.

Infectious Disease Screening

AI-powered, contactless screening that analyzes multispectral physiological indicators to detect infectious disease risk before symptoms spread.

Read More

Cannabis & Alcohol Impairment Screening

Advanced multispectral AI models identify real-time cannabis, alcohol, and opioid impairment through a fast, non-invasive walk-through process.

Read More

MobileWellbeing™ Remote Monitoring

AI-enabled remote patient monitoring platform using wearable devices to track vitals, detect anomalies, and support proactive virtual care.

Read More

Mental Illness Diagnostic Screening (R&D)

Developing non-invasive AI screening tools to help clinicians detect early indicators of depression, dementia, Alzheimer’s, and related conditions.

Read More
Qscreen Stations

From Screening Infrastructure to Healthcare Intelligence

Play
Insights

Company Press Release

Jul 20,2026
QScreen AI Deepens US Institutional Pipeline as Screening Platform Adds Escalation-Based Review Capability
Jul 14,2026
QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware
Jun 26,2026
QScreen AI Announces Adoption of Semi-Annual Reporting
Jun 25,2026
QScreen AI Announces Close of First Tranche of Private Placement
View More